Store-Operated Calcium Entry Contributes to Cisplatin-Induced Cell Death in Non-Small Cell Lung Carcinoma.
apoptosis
cisplatin
mitochondrial calcium
non-small cell lung carcinoma
reactive oxygen species
store-operated calcium entry
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
26 Mar 2019
26 Mar 2019
Historique:
received:
14
02
2019
revised:
19
03
2019
accepted:
22
03
2019
entrez:
29
3
2019
pubmed:
29
3
2019
medline:
29
3
2019
Statut:
epublish
Résumé
Cisplatin (CDDP) is one of the principal chemotherapeutic agents used for the first-line treatment of many malignancies, including non-small cell lung carcinoma (NSCLC). Despite its use for over 40 years, its mechanism of action is not yet fully understood. Store-operated calcium entry (SOCE), the main pathway allowing Ca
Identifiants
pubmed: 30917547
pii: cancers11030430
doi: 10.3390/cancers11030430
pmc: PMC6468672
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fonds De La Recherche Scientifique - FNRS
ID : J0080.17
Organisme : Fonds De La Recherche Scientifique - FNRS
ID : EQP U.N011.17
Organisme : Fédération Wallonie-Bruxelles
ID : ARC17/22-083
Commentaires et corrections
Type : ErratumIn
Références
J Biol Chem. 2000 Dec 15;275(50):39435-43
pubmed: 10993883
Biochem Pharmacol. 2002 Apr 15;63(8):1423-30
pubmed: 11996883
J Biol Chem. 2003 Mar 14;278(11):9100-6
pubmed: 12509415
FASEB J. 2006 Jan;20(1):136-8
pubmed: 16254044
Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):19-24
pubmed: 16415424
Int J Cancer. 2007 Jan 1;120(1):175-80
pubmed: 17044026
Physiol Rev. 2007 Jan;87(1):99-163
pubmed: 17237344
Br J Pharmacol. 2007 Aug;151(8):1176-86
pubmed: 17592515
Oncogene. 2008 Jul 10;27(30):4221-32
pubmed: 18362892
Exp Toxicol Pathol. 2009 May;61(3):223-42
pubmed: 18986801
Oncogene. 2011 Oct 13;30(41):4219-30
pubmed: 21516125
EMBO Rep. 2011 Oct 28;12(11):1182-8
pubmed: 21941299
J Biol Chem. 2012 May 11;287(20):16146-57
pubmed: 22451676
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):null
pubmed: 23378590
Exp Toxicol Pathol. 2013 Nov;65(7-8):1073-81
pubmed: 23714431
Oncogene. 2014 Aug 28;33(35):4385-95
pubmed: 24096476
PLoS One. 2013 Dec 17;8(12):e83638
pubmed: 24358303
Biochim Biophys Acta. 2014 Oct;1843(10):2263-9
pubmed: 24583265
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6389-94
pubmed: 24733904
Eur J Pharmacol. 2014 Oct 5;740:364-78
pubmed: 25058905
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2502-11
pubmed: 25150047
Biochimie. 2014 Dec;107 Pt B:257-62
pubmed: 25220870
J Toxicol Sci. 2014;39(5):765-74
pubmed: 25242407
Physiol Rev. 2015 Oct;95(4):1383-436
pubmed: 26400989
Biochim Biophys Acta. 2016 Jun;1860(6):1079-88
pubmed: 26922832
Sci Rep. 2016 Sep 14;6:33347
pubmed: 27624281
J Cell Mol Med. 2017 May;21(5):904-915
pubmed: 27878958
Cell Calcium. 2017 May;63:3-7
pubmed: 27914753
Cell Calcium. 2017 May;63:70-96
pubmed: 28143649
Cell Rep. 2017 Feb 21;18(8):1946-1957
pubmed: 28228260
Hum Cell. 2017 Jul;30(3):216-225
pubmed: 28326487
J Nephrol. 2018 Feb;31(1):15-25
pubmed: 28382507
Cancers (Basel). 2017 May 09;9(5):null
pubmed: 28486397
Sci Rep. 2017 Jun 9;7(1):3158
pubmed: 28600513
Physiology (Bethesda). 2017 Jul;32(4):332-342
pubmed: 28615316
Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5370-5377
pubmed: 29243778
Sci Rep. 2018 Mar 9;8(1):4306
pubmed: 29523854
Oncotarget. 2018 Mar 23;9(22):16059-16073
pubmed: 29662626
Biochim Biophys Acta Mol Cell Res. 2018 Nov;1865(11 Pt B):1786-1794
pubmed: 29842892
Nature. 1969 Apr 26;222(5191):385-6
pubmed: 5782119